David A. Kocisko

4.2k citations

33 papers · 3.3k indexed · 1 hit paper · h-index 24

Co-authors: Byron Caughey Peter T. Lansbury Gregory J. Raymond Suzette A. Priola Bruce Chesebro Jon H. Come Richard A. Bessen Santosh Nandan
Topics: Prion Diseases and Protein Misfolding (23 papers)Neurological diseases and metabolism (16 papers)Trace Elements in Health (15 papers)
Cited by: Neurology Nutrition and Dietetics Molecular Biology
Journals: Nature Proceedings of the National Academy of Sciences Journal of the American Chemical Society
Partner nations: United States Australia Thailand

In The Last Decade

David A. Kocisko

33 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cell-free formation of protease-resistant prion protein

1994 694 citations David A. Kocisko, Suzette A. Priola et al. Nature profile →

Peers

Countries citing papers authored by David A. Kocisko

Since Specialization

Citations

This map shows the geographic impact of David A. Kocisko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Kocisko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Kocisko more than expected).

Fields of papers citing papers by David A. Kocisko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Kocisko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Kocisko. The network helps show where David A. Kocisko may publish in the future.

Co-authorship network of co-authors of David A. Kocisko

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Kocisko. A scholar is included among the top collaborators of David A. Kocisko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Kocisko. David A. Kocisko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of 4-aminomethylphenylacetic acids as γ-secretase modulators via a scaffold design approach 2011 ·Bioorganic & Medicinal Chemistry Letters ·Zhili Xin,Hairuo Peng,Andrew Zhang,Tina Talreja,G. Kumaravel,Lin Xu,Ellen Rohde,(unknown),(unknown),David A. Kocisko,Sowmya Chollate,Anthone W. Dunah,(unknown),H. Moore Arnold,Arthur G. Taveras,Kenneth J. Rhodes,Robert H. Scannevin	15
2	The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific 2008 ·Transactions of the Royal Society of Tropical Medicine and Hygiene ·(unknown),Peter Nasveld,Scott Kitchener,David A. Kocisko,Michael D. Edstein	47
3	Cyclic Tetrapyrrole Sulfonation, Metals, and Oligomerization in Antiprion Activity 2007 ·Antimicrobial Agents and Chemotherapy ·Winslow S. Caughey,Suzette A. Priola,David A. Kocisko,Lynne D. Raymond,Anne Ward,Byron Caughey	30
4	Identification of prion inhibitors by a fluorescence-polarization-based competitive binding assay 2006 ·Analytical Biochemistry ·David A. Kocisko,(unknown),Roger A. Moore,Byron Caughey,Andrew Vaillant	9
5	Octapeptide repeat insertions increase the rate of protease‐resistant prion protein formation 2006 ·Protein Science ·Roger A. Moore,Christian Herzog,John S. Errett,David A. Kocisko,Kevin Arnold,Stanley F. Hayes,Suzette A. Priola	55
6	Gender differences in gastrointestinal disturbances and plasma concentrations of tafenoquine in healthy volunteers after tafenoquine administration for post-exposure vivax malaria prophylaxis 2006 ·Transactions of the Royal Society of Tropical Medicine and Hygiene ·Michael D. Edstein,Peter Nasveld,David A. Kocisko,Scott Kitchener,Michelle L. Gatton,Karl H. Rieckmann	13
7	A Porphyrin Increases Survival Time of Mice after Intracerebral Prion Infection 2006 ·Antimicrobial Agents and Chemotherapy ·David A. Kocisko,Winslow S. Caughey,Richard Race,(unknown),Byron Caughey,John D. Morrey	39
8	Searching for Anti‐Prion Compounds: Cell‐Based High‐Throughput In Vitro Assays and Animal Testing Strategies 2006 ·Methods in enzymology on CD-ROM/Methods in enzymology ·David A. Kocisko,Byron Caughey	20
9	Prions and Transmissible Spongiform Encephalopathy (TSE) Chemotherapeutics: A Common Mechanism for anti‐TSE Compounds? 2006 ·ChemInform ·Byron Caughey,Winslow S. Caughey,David A. Kocisko,(unknown),Jay R. Silveira,John D. Morrey	1
10	Comparison of protease-resistant prion protein inhibitors in cell cultures infected with two strains of mouse and sheep scrapie 2005 ·Neuroscience Letters ·David A. Kocisko,Abbi L. Engel,(unknown),Kevin Arnold,(unknown),Lynne D. Raymond,Didier Vilette,Byron Caughey	45
11	Mefloquine, an Antimalaria Drug with Antiprion Activity In Vitro, Lacks Activity In Vivo 2005 ·Journal of Virology ·David A. Kocisko,Byron Caughey	34
12	Plasma Concentrations of Tafenoquine, a New Long-Acting Antimalarial Agent, in Thai Soldiers Receiving Monthly Prophylaxis 2003 ·Clinical Infectious Diseases ·Michael D. Edstein,David A. Kocisko,Douglas S. Walsh,Chirapa Eamsila,B. G. Charles,Karl H. Rieckmann	30
13	New Inhibitors of Scrapie-Associated Prion Protein Formation in a Library of 2,000 Drugs and Natural Products 2003 ·Journal of Virology ·David A. Kocisko,Gerald S. Baron,Richard Rubenstein,(unknown),Salomon Kuizon,Byron Caughey	199
14	Measurement of Tafenoquine (WR 238605) in Human Plasma and Venous and Capillary Blood by High-Pressure Liquid Chromatography 2000 ·Therapeutic Drug Monitoring ·David A. Kocisko,Douglas S. Walsh,Chirapa Eamsila,Michael D. Edstein	18
15	Methods for Studying Prion Protein (PrP) Metabolism and the Formation of Protease-Resistant PrP in Cell Culture and Cell-Free Systems: An Update 1999 ·Molecular Biotechnology ·Byron Caughey,Gregory J. Raymond,Suzette A. Priola,David A. Kocisko,Richard Race,Richard A. Bessen,Peter T. Lansbury,Bruce Chesebro	26
16	Effects ofPlasmodium berghei infection on cytochromes P-450 2E1 and 3A2 1999 ·European Journal of Drug Metabolism and Pharmacokinetics ·(unknown),James M. Grace,David A. Kocisko,(unknown),(unknown),Thomas G. Brewer	7
17	Molecular assessment of the potential transmissibilities of BSE and scrapie to humans 1997 ·Nature ·Gregory J. Raymond,James Hope,David A. Kocisko,Suzette A. Priola,Lynne D. Raymond,Alex Bossers,James W. Ironside,Robert Will,Shu G. Chen,Robert B. Petersen,Pierluigi Gambetti,Richard Rubenstein,M.A. Smits,Peter T. Lansbury,Byron Caughey	197
18	Aggregates of scrapie-associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state 1995 ·Chemistry & Biology ·Byron Caughey,David A. Kocisko,Gregory J. Raymond,Peter T. Lansbury	155
19	Non-genetic propagation of strain-specific properties of scrapie prion protein 1995 ·Nature ·Richard A. Bessen,David A. Kocisko,Gregory J. Raymond,Santosh Nandan,Peter T. Lansbury,Byron Caughey	418
20	Structural model for the β-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide 1995 ·Nature Structural & Molecular Biology ·Peter T. Lansbury,Philip R. Costa,Janet M. Griffiths,Eric Simon,Michéle Auger,Kurt J. Halverson,David A. Kocisko,Zachary S. Hendsch,(unknown),Richard G. Spencer,Bruce Tidor,Robert G. Griffin	344

About David A. Kocisko

David A. Kocisko is a scholar working on Neurology, Nutrition and Dietetics and Molecular Biology, having authored 33 papers that have together received 3.3k indexed citations. Recurring topics across this work include Prion Diseases and Protein Misfolding (23 papers), Neurological diseases and metabolism (16 papers) and Trace Elements in Health (15 papers). The work is most often cited by research in Neurology (1.4k citations), Nutrition and Dietetics (1.1k citations) and Molecular Biology (2.8k citations). David A. Kocisko has collaborated with scholars based in United States, Australia and Thailand. Frequent co-authors include Byron Caughey, Peter T. Lansbury, Gregory J. Raymond, Suzette A. Priola, Bruce Chesebro, Jon H. Come, Richard A. Bessen, Santosh Nandan, Philip R. Costa and Robert G. Griffin. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact